Zynex, Inc. (ZYXI) |
| 0.125 0.073 (140.38%) 04-02 16:00 |
| Open: | 0.125 |
| High: | 0.125 |
| Low: | 0.125 |
| Volume: | 274,571 |
| Market Cap: | 4(M) |
| PE Ratio: | -0.05 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Distribution |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.15 |
| Resistance 1: | 0.13 |
| Pivot price: | 0.08 |
| Support 1: | 0.06 |
| Support 2: | 0.02 |
| 52w High: | 8.45 |
| 52w Low: | 0.0312 |
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
| EPS | -2.410 |
| Book Value | -1.340 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.564 |
| Profit Margin (%) | -68.35 |
| Operating Margin (%) | -98.97 |
| Return on Assets (ttm) | -27.1 |
| Return on Equity (ttm) | 0.0 |
Fri, 27 Mar 2026
Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to - GlobeNewswire
Thu, 26 Mar 2026
Zynex (NASDAQ: ZYXI) leaves Chapter 11; new sponsor takes full control - Stock Titan
Fri, 20 Mar 2026
Zynex (ZYXI) Chapter 11 plan cancels common stock and reorganizes - Stock Titan
Tue, 27 Jan 2026
Zynex hires security amid retaliation fears as founder denied bail in fraud case - The Business Journals
Fri, 19 Dec 2025
Zynex Enters Chapter 11 and Faces Nasdaq Delisting - The Globe and Mail
Tue, 16 Dec 2025
Zynex Financial Restructuring Puts Company on Path to Long-Term Success - PR Newswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |